{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:16:47Z","timestamp":1793128607612,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003727","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000}}],"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"unitaid","award":["ACCESS-SMC"],"award-info":[{"award-number":["ACCESS-SMC"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Seasonal malaria chemoprevention (SMC) has shown high protective efficacy against clinical malaria and severe malaria in a series of clinical trials. We evaluated the effectiveness of SMC treatments against clinical malaria when delivered at scale through national malaria control programmes in 2015 and 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      Case\u2013control studies were carried out in Mali and The Gambia in 2015, and in Burkina Faso, Chad, Mali, Nigeria, and The Gambia in 2016. Children aged 3\u201359 months presenting at selected health facilities with microscopically confirmed clinical malaria were recruited as cases. Two controls per case were recruited concurrently (on or shortly after the day the case was detected) from the neighbourhood in which the case lived. The primary exposure was the time since the most recent course of SMC treatment, determined from SMC recipient cards, caregiver recall, and administrative records. Conditional logistic regression was used to estimate the odds ratio (OR) associated with receipt of SMC within the previous 28 days, and SMC 29 to 42 days ago, compared with no SMC in the past 42 days. These ORs, which are equivalent to incidence rate ratios, were used to calculate the percentage reduction in clinical malaria incidence in the corresponding time periods. Results from individual countries were pooled in a random-effects meta-analysis. In total, 2,126 cases and 4,252 controls were included in the analysis. Across the 7 studies, the mean age ranged from 1.7 to 2.4 years and from 2.1 to 2.8 years among controls and cases, respectively; 42.2%\u201350.9% and 38.9%\u201346.9% of controls and cases, respectively, were male. In all 7 individual case\u2013control studies, a high degree of personal protection from SMC against clinical malaria was observed, ranging from 73% in Mali in 2016 to 98% in Mali in 2015. The overall OR for SMC within 28 days was 0.12 (95% CI: 0.06, 0.21;\n                      <jats:italic>p &lt;<\/jats:italic>\n                      0.001), indicating a protective effectiveness of 88% (95% CI: 79%, 94%). Effectiveness against clinical malaria for SMC 29\u201342 days ago was 61% (95% CI: 47%, 72%). Similar results were obtained when the analysis was restricted to cases with parasite density in excess of 5,000 parasites per microlitre: Protective effectiveness 90% (95% CI: 79%, 96%; P&lt;0.001), and 59% (95% CI: 34%, 74%; P&lt;0.001) for SMC 0\u201328 days and 29\u201342 days ago, respectively. Potential limitations include the possibility of residual confounding due to an association between exposure to malaria and access to SMC, or differences in access to SMC between patients attending a clinic and community controls; however, neighbourhood matching of cases and controls, and covariate adjustment, attempted to control for these aspects, and the observed decline in protection over time, consistent with expected trends, argues against a major bias from these sources.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SMC administered as part of routine national malaria control activities provided a very high level of personal protection against clinical malaria over 28 days post-treatment, similar to the efficacy observed in clinical trials. The case\u2013control design used in this study can be used at intervals to ensure SMC treatments remain effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1003727","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T13:31:45Z","timestamp":1631107905000},"page":"e1003727","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":92,"title":["Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case\u2013control studies in 5 countries"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1068-9713","authenticated-orcid":true,"given":"Matthew","family":"Cairns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serign Jawo","family":"Ceesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-4713","authenticated-orcid":true,"given":"Issaka","family":"Zongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamit","family":"Kessely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadidja","family":"Gamougam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-2560","authenticated-orcid":true,"given":"Johnbull Sonny","family":"Ogboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1872-8684","authenticated-orcid":true,"given":"Diego","family":"Moroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Van Hulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Eloike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-6033","authenticated-orcid":true,"given":"Susana","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-365X","authenticated-orcid":true,"given":"Corinne","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalifa","family":"Bojang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-8733","authenticated-orcid":true,"given":"Jean Bosco","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-8427","authenticated-orcid":true,"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-5551","authenticated-orcid":true,"given":"Jean-Louis","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3430-3395","authenticated-orcid":true,"given":"Paul","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"pmed.1003727.ref001","first-page":"CD003756","article-title":"Intermittent preventive treatment for malaria in children living in areas with seasonal transmission","volume":"2","author":"MM Meremikwu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1003727.ref002","volume-title":"WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"World Health Organization","year":"2012"},{"key":"pmed.1003727.ref003","volume-title":"OPT-SMC: SMC in 2020","author":"London School of Hygiene & Tropical Medicine","year":"2021"},{"issue":"10265","key":"pmed.1003727.ref004","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","article-title":"Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study","volume":"396","author":"ACCESS-SMC Partnership","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"pmed.1003727.ref005","doi-asserted-by":"crossref","first-page":"e12618","DOI":"10.1371\/journal.pone.0012618","article-title":"Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance","volume":"5","author":"JT Griffin","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"pmed.1003727.ref006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/civ881","article-title":"Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight","volume":"62","author":"M Desai","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pmed.1003727.ref007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12936-017-1974-x","article-title":"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali","volume":"16","author":"F Diawara","year":"2017","journal-title":"Malar J"},{"issue":"2","key":"pmed.1003727.ref008","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4269\/ajtmh.17-0599","article-title":"Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a quasi-experimental study in Burkina Faso","volume":"98","author":"T Druetz","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"18","key":"pmed.1003727.ref009","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3390\/ijerph17186639","article-title":"Two-year scale-up of seasonal malaria chemoprevention reduced malaria morbidity among children in the health district of Koutiala, Mali","volume":"17","author":"H Maiga","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"25","key":"pmed.1003727.ref010","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls","volume":"35","author":"JR Verani","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"pmed.1003727.ref011","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4269\/ajtmh.2005.73.140","article-title":"Case-control study of mosquito nets against malaria in the Amazon region of Colombia","volume":"73","author":"N Alexander","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pmed.1003727.ref012","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0035-9203(97)90502-2","article-title":"The Gambian National Impregnated Bed Net Programme: evaluation of effectiveness by means of case-control studies","volume":"91","author":"U D\u2019Alessandro","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"pmed.1003727.ref013","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","article-title":"On the need for the rare disease assumption in case-control studies","volume":"116","author":"S Greenland","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pmed.1003727.ref014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ije\/19.1.205","article-title":"Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls","volume":"19","author":"L Rodrigues","year":"1990","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pmed.1003727.ref015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12936-018-2371-9","article-title":"How long do rapid diagnostic tests remain positive after anti-malarial treatment?","volume":"17","author":"U Dalrymple","year":"2018","journal-title":"Malar J"},{"key":"pmed.1003727.ref016","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/01621459.1949.10483314","article-title":"A procedure for objective respondent selection within the household","volume":"44","author":"L Kish","year":"1949","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"pmed.1003727.ref017","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/AAC.04923-14","article-title":"Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso","volume":"59","author":"I Zongo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pmed.1003727.ref018","doi-asserted-by":"crossref","first-page":"e1000407","DOI":"10.1371\/journal.pmed.1000407","article-title":"Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"A Dicko","year":"2011","journal-title":"PLoS Med"},{"issue":"2","key":"pmed.1003727.ref019","doi-asserted-by":"crossref","first-page":"e1000408","DOI":"10.1371\/journal.pmed.1000408","article-title":"Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"AT Konate","year":"2011","journal-title":"PLoS Med"},{"key":"pmed.1003727.ref020","unstructured":"WHO\/GMP Technical expert group on preventive chemotherapy. Report of the Technical consultation on Seasonal Malaria Chemoprevention (SMC)\/Chimio-pr\u00e9vention saisonni\u00e8re du paludisme (CSP). 2011. https:\/\/www.who.int\/malaria\/publications\/atoz\/smc_report_teg_meetingmay2011.pdf"},{"issue":"11","key":"pmed.1003727.ref021","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/aje\/155.11.1066","article-title":"Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined design","volume":"155","author":"C Lienhardt","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pmed.1003727.ref022","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ije\/22.4.742","article-title":"Estimation of vaccine effectiveness using the screening method","volume":"22","author":"CP Farrington","year":"1993","journal-title":"Int J Epidemiol"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003727","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T14:42:35Z","timestamp":1632321755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003727"}},"subtitle":[],"editor":[{"given":"Elizabeth A.","family":"Ashley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003727","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]}}}